期刊文献+

丁酸钠增强U937细胞凋亡敏感性的分子机制研究 被引量:1

Molecular mechanism of enhanced apoptotic response in U937 cells mediated by sod ium butyrate
原文传递
导出
摘要 目的 探讨丁酸钠 (NaBu)对细胞周期检测点效应及对U937细胞凋亡的敏感性。方法以U937 ASPI3K(ATM阴性 )、U937 pZeosv2 (+) (野生型ATM基因 )两种U937的变异细胞系作为细胞模型。用免疫沉淀及激酶活性测定p38MAPK、ERK1的激酶活性。用免疫印迹分析Bad磷酸化灭活。结果 经NaBu预处理的U937 pZeosv2 (+)细胞经13 7Cs照射后 ,细胞凋亡敏感性呈NaBu剂量依赖性增强。这种增强效应可被p38MAPK阻滞剂OLM阻断 ,但不能被p34cdc2激酶的特异性抑制剂ALP及CDK2阻滞剂CDK2 Ⅰ阻断。经NaBu预处理的U937 ASPI3K细胞经13 7Cs照射后 ,细胞凋亡敏感性进一步增强 ,这种增强效应可被OLM阻断。放射线可显著增强p38MAPK激酶活性 ,抑制ERK1激酶活性 ;NaBu预处理与放射线联用后 ,对p38MAPK激酶活性的增强有极其显著的协同效应。放射线诱导U937 ASPI3K细胞Bad蛋白磷酸化灭活 ,在NaBu协同作用下 ,Bad蛋白磷酸化灭活效应进一步增强。结论 NaBu通过p38MAPK激酶活性 ,增强细胞凋亡敏感性 ,该效应与ATM基因是否缺失无关 。 Objective To study the effects of sodium butyrate (NaBu) on cell cycle checkpoint and the apoptosis sensitivity in U937 cells. Methods Two mutant U937 cell lines, U937 ASPI3K (ATM negative) and U937 pZeosv2(+) (AT M wild type), were used as the cell model system. Immunoprecipitation and kina se assay were used to examine the p38 MAPK and ERK1 kinase activities. Western b lot was used to analyze the phosphorylation of Bad protein. Results U937 pZeosv2(+) pretreated with NaBu exhibited enhanced apoptotic response in a NaBu dose dependent fashion upon 137 Cs irradiation, which could be abol is hed by olomoucine (OLM), a p38 MAPK specific inhibitor. On the other hand, Cycli n dependent kinase 2 (CDK2) specific inhibitor CDK2 Ⅰ and p34cdc2/cyclinB inhi bitor alsterpaullone (ALP) failed to block the effects of NaBu. Similar results were also observed in U937 ASPI3K. The effect of irradiation on p38 MAPK and ER K1 was strikingly potentiated by NaBu. Furthermore, inactivation of irradiated B ad protein via phosphorylation on serine 136 was also enhanced. Conclusion NaBu is able to enhance the apoptotic response in U937 cells, which is mediated by p38 MAPK activation but not ATM status. [WT5'HZ
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2002年第4期320-320,共1页 Chinese Journal of Oncology
基金 国家自然科学基金资助项目 (3 980 0 14 9)
关键词 丁酸钠 U937细胞 细胞凋亡敏感性 ATM基因 分子机制 P38MAPK Sodium butyrate U937 cells Apoptosis Oligonucleotide, antisense, ATM
  • 相关文献

参考文献3

二级参考文献11

  • 1Yang J,Science,1997年,275卷,1129页
  • 2Shiloh Y. Ataxia-telangiectasia:closer to unraveling the mys-tery. Eur J Hum Genet, 1995; 3:116- 138
  • 3Harnden DG. The nature of ataxia-telangiectasia: problems andprospectives. Int JRadiat Biol, 1994; 66(6 Suppl):S13- 19
  • 4Savitsky K, Bar-Shira S, Gilad G, et al. A single ataxia-telangiectasia gene with aproduct similar to PI-3 kinase. Science,1995; 268:1749 - 1753
  • 5Savitsky K, Sfez S, Tagle DA, et al. The complete sequenceof the coding region ofthe ATM gene reveals similarity to cellcycle regulators in different species. Hum MolGenet, 1995; 4:2025 - 2032
  • 6Morgan SE, Lovly C, Pandita TK, et al. Fragments of ATMwhich have dominant-negativeor complementing activity. MolCell Biol, 1997; 17:2020-2029
  • 7Boral AL, Dessain S, Chabner BA. Clinical evaluation of bio-logically targeteddrugs: obstacles and opportunities. CancerChemother Pharmacol, 1998; 42(Suppl) :S3 - S21
  • 8Zhang N, Chen P, Gatei M, et al. An anti-sense construct offull length ATM cDNAimposes a radiosensitive phenotype onnormal cells. Oncogene, 1998; 17:811 -818
  • 9Shiloh Y, Parshad R, Sarford KK, et al. Carrier detection inataxia-telangiectasia.Lancet, 1986; 1:689 - 690
  • 10O′Connor PM, Fan S. DNA damage checkpoints: implicationsfor cancer therapy, ProgCell Cycle Res, 1996; 2:165 - 173

共引文献6

同被引文献22

  • 1赵洁,苏琦.组蛋白乙酰化/去乙酰化与白血病的研究进展[J].肿瘤学杂志,2004,10(6):436-439. 被引量:19
  • 2Hinnebusch BF, Meng S, Wu JT, Archer SY, Hodin RA. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr2002;132:1012-1017.
  • 3Yoshida M, Furumai R, Nishiyama M, Komatsu Y, Nishino N,Horinouchi S. Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemother Pharmacol 2001;48:20-26.
  • 4Huang L, Sowa Y, Sakai T, Pardee AB. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)through the Splsites. Oncogene 2000;19:5712-5719.
  • 5Magdinier F, Wolffe AP. Selective association of the methylCpG binding protein MBD 2 with the silent p14/p16 locus in human neoplasia. Proc Natl Acad Sci USA 2001;98:4990-4995.
  • 6Munster PN, Troso-Sandoval T, Rosen N, Rifkind R, Marks PA, Richon VM. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. Cancer Res 2001;61:8492-8497.
  • 7Weidle UH, Grossmann A. Inhibition of histone deacetylases:a new strategy to target epigenetic modifications for anticancer treatment. Anticancer Res 2000;20:1471-1485.
  • 8Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA,Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000;403:98-103.
  • 9Desagher S, Martinou JC. Mitochondria as the contral control point of apoptosis. Trends Cell Biol 2000;10:369-377.
  • 10Foyouzi-Youssefi R, Arnaudeau S, Borner C, Kelley WL,Tschopp J, Lew DP, Demaurex N, Krause KH. Bcl-2 decreases the free Ca++ concentration within the endoplasmic reticulum.Proc Natl Acad Sci USA 2000;97:5723-5728.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部